NEW DELHI (The Straits TImes/Asia News Network): India has been taking measures to wean off dependence on China for ingredients that go into making a variety of drugs, including antibiotics.
But three years after the Covid-19 pandemic disrupted supply chains from China, India is still a long way off from reducing imports of active pharmaceutical ingredients (APIs) – chemicals responsible for the therapeutic effect of drugs, noted industry experts.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
